Quarterly report [Sections 13 or 15(d)]

Segments (Details)

v3.25.1
Segments (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Stock-based compensation expense $ 3,241 $ 629
Reportable Segment    
Segment Reporting Information [Line Items]    
Nonclinical expenses 83 152
Clinical expenses 3,850 62
CMC expenses 1,979 254
Salaries, benefits and related costs 1,850 1,324
Stock-based compensation expense 1,301 269
Other 60 55
Research and development expense $ 9,123 $ 2,116